First Italian real-world results on the tolerability of the adjuvanted RSV vaccine in adults aged 60 and over published in Vaccine: X
The study titled “Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults” was recently published…


